Evidence map›Paper›PMID 35483961›Full record

ArticleGenome research2022

A complete pedigree-based graph workflow for rare candidate variant analysis.

Charles Markello, Charles Huang, Alex Rodriguez, Andrew Carroll, Pi-Chuan Chang, Jordan Eizenga, Thomas Markello, David Haussler, Benedict Paten

Abstract read
In one paragraph

Article in Genome research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. From complete genomes to pangenomes.American journal of human genetics · 2024
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Charles MarkelloUC Santa Cruz Genomics Institute, Santa Cruz, California 95060, USA.ORCID 0000-0002-3653-7155
Charles HuangUndiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20894, USA.
Alex RodriguezUndiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20894, USA.
Andrew CarrollGoogle Incorporated, Mountain View, California 94043, USA.ORCID 0000-0002-4824-6689
Pi-Chuan ChangGoogle Incorporated, Mountain View, California 94043, USA.
Jordan EizengaUC Santa Cruz Genomics Institute, Santa Cruz, California 95060, USA.ORCID 0000-0001-8345-8356
Thomas MarkelloUndiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20894, USA.
David HausslerUC Santa Cruz Genomics Institute, Santa Cruz, California 95060, USA.
Benedict PatenUC Santa Cruz Genomics Institute, Santa Cruz, California 95060, USA.ORCID 0000-0001-8863-3539

Funding

The WashU-UCSC-EBI Human Genome Reference Center."U41HG010972 · NHGRI · WASHINGTON UNIVERSITY · PI Ira M Hall, Heng Li · 2019 to 2026
$24.9M
The Integration of Trans-omics for Precision Medicine (TOPMED) and Other Heart, Lung, Blood and Sleep (HLBS) Data Sets with the Data CommonsOT3HL142481 · NHLBI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI GROSSMAN, ROBERT L., PATEN, BENEDICT · 2017 to 2020
$24.9M
GENCODE Resource ProjectU41HG007234 · NHGRI · SANGER INSTITUTE · PI FLICEK, PAUL · 2013 to 2020
$20.3M
Comprehensive, Flexible and FAIR Tools for the HuBMAP HIVEOT2OD026682 · OD · CARNEGIE-MELLON UNIVERSITY · PI PATEN, BENEDICT, RUFFALO, MATTHEW · 2018 to 2021
$3.4M
The construction and utility of reference pan-genome graphsU01HG010961 · NHGRI · DANA-FARBER CANCER INST · PI LI, HENG, PATEN, BENEDICT · 2020 to 2023
$3.2M
Enabling Comparative PangenomicsR01HG010485 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAUSSLER, DAVID H, MARTIN, FERGAL JAMES · 2020 to 2023
$2.6M
Unbiased analysis of genomic correlates of gene expression in health and diseaseU01HL137183 · NHLBI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAUSSLER, DAVID H · 2017 to 2019
$1.8M
NHGRI NIH HHS R01 HG010485NHGRI NIH HHS U01 HG010961NHGRI NIH HHS U41 HG007234NHGRI NIH HHS U41 HG010972NHLBI NIH HHS OT3 HL142481NHLBI NIH HHS U01 HL137183NIH HHS OT2 OD026682
6 · The paper itself

Abstract

Methods that use a linear genome reference for genome sequencing data analysis are reference-biased. In the field of clinical genetics for rare diseases, a resulting reduction in genotyping accuracy in some regions has likely prevented the resolution of some cases. Pangenome graphs embed population variation into a reference structure. Although pangenome graphs have helped to reduce reference mapping bias, further performance improvements are possible. We introduce VG-Pedigree, a pedigree-aware workflow based on the pangenome-mapping tool of Giraffe and the variant calling tool DeepTrio using a specially trained model for Giraffe-based alignments. We demonstrate mapping and variant calling improvements in both single-nucleotide variants (SNVs) and insertion and deletion (indel) variants over those produced by alignments created using BWA-MEM to a linear-reference and Giraffe mapping to a pangenome graph containing data from the 1000 Genomes Project. We have also adapted and upgraded deleterious-variant (DV) detecting methods and programs into a streamlined workflow. We used these workflows in combination to detect small lists of candidate DVs among 15 family quartets and quintets of the Undiagnosed Diseases Program (UDP). All candidate DVs that were previously diagnosed using the Mendelian models covered by the previously published methods were recapitulated by these workflows. The results of these experiments indicate that a slightly greater absolute count of DVs are detected in the proband population than in their matched unaffected siblings.

Indexed as

GenomePolymorphism, Single NucleotideHigh-Throughput Nucleotide SequencingINDEL MutationPedigreeSoftwareWorkflow

Identifiers

PMID35483961
PMCPMC9104704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.